Zobrazeno 1 - 10
of 1 748
pro vyhledávání: '"Chronic daily headache"'
Publikováno v:
Nutrition & Food Science, 2022, Vol. 53, Issue 6, pp. 1022-1032.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/NFS-05-2022-0145
Autor:
Sanjay Cheema, Anker Stubberud, Khadija Rantell, Parashkev Nachev, Erling Tronvik, Manjit Matharu
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background It is unknown whether new daily persistent headache (NDPH) is a single disorder or heterogenous group of disorders, and whether it is a unique disorder from chronic migraine and chronic tension-type headache. We describe a large g
Externí odkaz:
https://doaj.org/article/be7d3ee548224a6da4a2bac711f4845a
Autor:
Da-Ming Liao, Chieh Chen
Publikováno v:
Tungs’ Medical Journal, Vol 17, Iss 1, Pp 1-5 (2023)
Most cases of intractable headaches are primary and functional in nature, and secondary headaches due to subarachnoid hemorrhage are not included in this category. Primary headache can be divided into the following two types: migraine and chronic ten
Externí odkaz:
https://doaj.org/article/6f868cf18d7a44f894aa6d3a5cf117c0
Autor:
Jennifer Robblee
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundRefractory migraine is a poorly described complication of migraine in which migraine has chronified and become resistant to standard treatments. The true prevalence is unknown, but medication resistance is common in headache clinic patient
Externí odkaz:
https://doaj.org/article/7e3e639927c74f09b25aafdc3033005a
Autor:
Maram Alshareef
Publikováno v:
Clinics and Practice, Vol 12, Iss 5, Pp 714-722 (2022)
The prevalence of chronic daily headache (CDH) worldwide is 4–5%. Treatment for CDH with prophylaxis and abortive medications is often delayed, increasing disease severity. Consequently, increased usage of over-the-counter (OTC) analgesics can lead
Externí odkaz:
https://doaj.org/article/8bc902fdc483493b9b9dcac503b5759a
Autor:
Armin Scheffler, Hannah Schenk, Sebastian Wurthmann, Michael Nsaka, Christoph Kleinschnitz, Martin Glas, Dagny Holle
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-6 (2021)
Abstract Background Calcitonin gene-related peptide (CGRP) (receptor) antibodies (erenumab, fremanezumab and galcanezumab) are increasingly used in prophylactic treatment of migraine. In the approval studies, severely affected patients with migraine
Externí odkaz:
https://doaj.org/article/b731ecb7817c491b94df4ef044ea44d5
Publikováno v:
Frontiers in Human Neuroscience, Vol 16 (2022)
Externí odkaz:
https://doaj.org/article/a64e72d11d6a44ed84936b5f85cf3e8e
Autor:
Ann Ali AbdElkader, Ebtesam Mohammed Fahmy, Ayat Allah Farouk Ahmad, Amira A. Labib, Leqaa Ali El-Mekkawy, Shaimaa shaheen Mohammed Abd El Razek
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 57, Iss 1, Pp 1-7 (2021)
Abstract Background Headache is the most common pain disorder , affecting around 66% of the global population. This study aimed to investigate the efficacy of high-frequency repetitive transcranial magnetic stimulation (rTMS) in treating patients wit
Externí odkaz:
https://doaj.org/article/b7aca2794e864192b653adc602ab7427
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Masahito Katsuki, Junko Kawahara, Yasuhiko Matsumori, Chinami Yamagishi, Akihito Koh, Shin Kawamura, Kenta Kashiwagi, Tomohiro Kito, Akio Entani, Toshiko Yamamoto, Miyako Otake, Takashi Ikeda, Fuminori Yamagishi
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 16, p 4707 (2022)
Background: The prevalence of headache disorders, migraine, chronic daily headache (CDH), and medication-overuse headache (MOH) among the elderly in Japan has not been sufficiently investigated. We performed a questionnaire-based survey and revealed
Externí odkaz:
https://doaj.org/article/2235f5ae86484255b79af347ac6b3194